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Summary 
Extracts of the anterior lobe and intermediate lobe of 
postnatal (P) (Day PI, P7, P14, P21, P28, P35, P42) and adult 
male Spraque-Dawley rats were analyzed by both a Beta-endorphin 
(B-END) radioimmunoassay and a radioimmunoassay for N-acetyl- 
B-END. In the anterior lobe, on PI, less than 2% of the adult 
level of B-END was present. By P42 this level had increased to 
21% of adult levels. In the intermediate lobe, on PI, the B-END 
levels were less than 0.1% of the adult level, and by P42 this 
level approached approximately 45% of the adult levels. 
N-acetylated B-END was identified in both anterior lobe and 
intermediate lobe from PI through adulthood. In the anterior 
lobe at PI, N-acetyl-B-END immunoreactivity contributes approxi- 
mately 25% of the total B-END immunoreactivity. This level 
drops to less than 10% by P21, and to adult-like levels by P42 
(less than 5%). On the other hand, in the intermediate lobe, 
the N-acetyl-B-END levels start at 70% of the total B-END 
immunoreactivity at PI and by P14 reaches adult-like proportions 
of 90% or more of the total B-END immunoreactive material. 
The differential post-translational processing of B-Endorphin (B-END) in 
the anterior and intermediate lobes of the pituitary in adult rat has been 
well characterized (1,2,3). An important post-translational process in the 
intermediate pituitary is the N-acetylation of different B-END derivatives. 
In fact, several different N-acetylated derivatives of B-END have been shown 
to occur in the intermediate pituiary of adults from a number of different 
species. The N-acetylation at the amino-terminal tyrosine residue is an 
important modification which results in almost a complete loss3in analgesic 
potency and over a 1000-fold drop in the ability to displace [ H]-B-END from 
brain binding sites (4,5). 
To date, the ontogenetic studies of B-END have primarily focused on the 
development of immunohistological staining of B-END-containing cells in the 
embryo, or the differential development of B-END as compared to other opioid 
peptides (6,7,8). These studies have clearly demonstrated the early 
presence of B-END staining in the diencephalic area (arcuate nucleus) at 
E12, and the subsequent and differential development of B-END in the 
anterior lobe (E15) and intermediate lobe (E17). Now with the development 
of antibodies specific for the acetylated forms of B-END, this modification 
can be investigated to determine not only its physiological significance but 
0024-3205/83 $3.00 + .00 
Copyright (c) 1983 Pergamon Press Ltd. 
58 Ontogeny of B-endorphin Vol. 33, Sup. I, 1983 
its alterations during development. 
The current study investigates the ontogeny of both B-END immunoreactiv- 
ity and N-acetylated B-END immunoreactivity in the anterior and intermediate 
lobes of the pituitary during postnatal development in the male rat. 
Methods 
Dissection/Tissue Preparation: Postnatal male Sprague-Dawley rats were 
sacrificed by decapitation at one week age intervals from day PI to P42, as 
were adults. Brains were immediately dissected from the skull, and the 
pituitaries were removed and micro-dissected. The intermediate lobe was 
peeled from the anterior lobes, then the medial portion of the anterior lobe 
was dissected and discarded. Immediately following the dissection, all 
• O . 
speclmens were frozen and stored at -80 C untll further processing. At that 
time each pituitary specimen (intermediate lobe or anterior lobe) was placed 
in 2 ml 0.1N HC1 and Acetone (1:3) at 4°C, then homogenized for 10 sec using 
a Polytron. After aliquots of this solution were taken for protein 
determination, these specimens were centrifuged at 10,000 r~m for 20 min. 
The supernatant was taken, lyophilized, and stored at -20-C until the time 
of assay. 
B-END RADIOIMMUNOASSAY. The antiserum "Brenda" used in this assay is 
directed to the midportion of B-END. At a final antibody concentration of 
1:30,000, this results in 100% cross-reactivity with all forms of B-END, 
Proopiomelanocortin and B-Lipotropin and the N-acetylated forms of B-END. 
All tracers are iodinated by the standard chloramine-T method. The IC50 
with this antibody is 30 fm/assay tube. 
NTacet~l-B-END Radioimmunoassa~. The Radioimmunoassay for N-acetylated 
forms of B-END uses the antibody, from the rabbit "Nancy-Beth" at a final 
concentration of 1:6,000. This antiserum relies completely on N-acetylation 
of the tyrosine-glycine-glycine-phenylalanine core as its recognition site 
and detects equally all N-acetylated opioids. The assay conditions are 
similar to those of B-END. The IC50 is 200 fm/assay tube. 
Results 
Table I shows the B-END and N-acetylated B-END immunoreactivity 
contained within the extracts of the anterior lobe and intermediate lobe 
from each stated age. From PI to P42 the levels of B-END increase 12 fold 
in the anterior lobe and 214 fold in the intermediate lobe. From P42 to 
adulthood in the anterior lobe, B-END increases a further 5 fold, resulting 
in a total increase of greater than 50 fold from PI to adulthood. In the 
intermediate lobe the total increase from PI to adulthood is greater than 
470 fold. Further, the patterns of increase in the intermediate lobe is 
different than that in the anterior lobe. Following comparable rates of 
increase in B-END levels from PI to P7, the levels of B-END increases at an 
accelerated rate in the intermediate lobe whereas in the anterior lobe a 
marked increase in B-END levels does not occur until the onset of puberty 
(P35-P42). 
N-acetylation of B-END is present at birth in the anterior lobe and 
intermediate lobe. At PI, the N-acetylation of B-END in the anterior 
pituitary is substantial, making up almost 25% of the total B-END material. 
This level of acetylation drops to approximately 9% of the total B-END level 
by P28, then to adult-like levels (less than 5%) by P42. In the 
intermediate lobe, the acetylation of B-END begins at 70% at PI, and 
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Discussion 
This study clearly demonstrates the differences in the postnatal 
development of B-END immunoreactivity and N-acetylated B-END immunoreactiv- 
ity in the anterior and intermediate lobes of the male rat pituitary. The 
level of B-END immunoreactivity at PI is greater in the anterior lobe than 
intermediate lobe. By P7, the levels of B-END immunoreactivity in the 
intermediate lobe have begun to surpass the levels in the anterior lobe. 
This pattern continues, with the levels of B-END in the intermediate lobe 
rising more rapidly throughout development. On the other hand, the level of 
B-END in the anterior lobe rises slowly and does not change rapidly until 
near or after puberty (P35-42). 
N-acetylation of B-END is found throughout postnatal development in both 
the anterior lobe and the intermediate lobe. Also, immunohistological 
staining for a-MSH (8) and other radioimmunoassay data (unpublished) 
indicate that the N-acetylation of proopiomelanocortin related peptides 
begins in utero. Of further interest is the relatively high level of 
N-acetylated B-END in the anterior pituitary at PI which subsequently 
decreases to adult levels by P28. A parallel process which occurs in the 
anterior pituitary corticotrophs is the gradual postnatal decrease in 
alpha-MSH immunostaining from PI to P14, and the subsequent loss of 
immunorectivity by P28. This suggests that during development there is a 
period during which the anterior pituitary processes proopiomelanocortin 
peptides much the same way as the intermediate pituitary. These differences 
in post-translational alterations in the processing of B-END during 
development also suggests that there are factors which influence these 
processes in the anterior lobe in utero and following birth, but soon 
subside. To what degree these factors can subsequently become 
physiologically reactivated is unknown, as is the significance of the 
presence of N-acetylated peptides in the anterior pituitary during 
development. 
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